Command Palette
Search for a command to run...
Shivalik Rasayan
NSE: SHIVALIKBSE: 539148CHEMICALS & PETROCHEMICALSAGROCHEMICALS
Market Cap
--
P/E Ratio
0.00
P/B Ratio
0.00
ROE
0.00%
ROA
0.00%
Debt/Equity
0.00
Book Value
₹0.0
EPS
₹0.0
About Shivalik Rasayan
Shivalik Rasayan The Company is a manufacturer of Agrochemicals & Active Pharma Ingredients (API).
Shivalik Rasayan Limited (SRL) was registered with the ROC, Gwalior, Madhya Pradesh dated 16 March, 1979. SRL has emerged amongst India's niche agrochemical market leader. It is a manufacturer of Organophosphate Insecticides such as Dimethoate Technical and Malathion Technical in India. In 2016-17, the Company acquired 44.12% equity shares of M/s Medicamen Biotech Limited in accordance with the Share Purchase Agreement with Promoters of M/s Medicamen Biotech Limited. The Company took over the full management control in Medicamen Biotech Limited on 1st January 2016. The Company purchased 21,000 equity shares of its Associate Company i.e. Medicamen Biotech Limited from open market, thereby increasing its stake to 41.96% in 2022. The new Agro & Specialty Chemical Plant started at Dahej-III was commissioned in April, 2023. Agrochemical and Synthetic Organic Chemical Plant started commercial production from April, 2024. The Company launched a 2,000 MT per annum capacity block for insecticides and fungicides in FY24. During 2024-25, SRL has purchased 21,000 Equity Shares of its Associate Company, Medicamen Biotech Limited from open market thereby increasing its stake to 43.16%.
Price Action • SHIVALIK
Financial Statements
Consolidated & Standalone Reports
| Metric | TTM | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 | Mar '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 174.97 | 151.29 | 95.33 | 95.78 | 101.29 | 85.24 | 61.98 | 52.28 | 44.34 | 41.46 | 43.15 | 41.71 |
Operating Expenses | 145.67 | 122.88 | 76.61 | 74.51 | 76.1 | 66.14 | 51.33 | 41.7 | 36.33 | 34.17 | 37.74 | 38.47 |
Operating Profit | 27.21 | 26.35 | 17.07 | 19.07 | 23.21 | 18.73 | 9.44 | 6.24 | 7.3 | 6.77 | 4.86 | 2.83 |
Operating Margin (%) | - | 17.41 | 17.91 | 19.91 | 22.91 | 21.97 | 15.23 | 11.94 | 16.46 | 16.33 | 11.25 | 6.79 |
Total Expenses | - | 137.76 | 85.12 | 81.16 | 82.43 | 72.71 | 53.26 | 43.63 | 37.97 | 36.51 | 39.16 | 38.99 |
EBITDA | - | 28.41 | 18.72 | 21.27 | 25.19 | 19.11 | 10.64 | 10.58 | 8.02 | 7.29 | 5.41 | 3.25 |
EBITDA Margin (%) | - | 18.78 | 19.64 | 22.21 | 24.87 | 22.41 | 17.17 | 20.24 | 18.08 | 17.59 | 12.54 | 7.78 |
Interest Expenses | 6.25 | 6.18 | 3.23 | 1.42 | 1.09 | 0.51 | 0.92 | 1.12 | 1.3 | 1.97 | 1.05 | 0.34 |
Depreciation | 10.82 | 8.7 | 5.28 | 5.24 | 5.24 | 6.06 | 1.01 | 0.82 | 0.34 | 0.38 | 0.38 | 0.18 |
Profit Before Tax (PBT) | 12.24 | 13.53 | 10.21 | 14.62 | 18.86 | 12.53 | 8.71 | 8.65 | 6.37 | 4.94 | 3.99 | 2.72 |
Tax Expenses | 1.48 | -0.34 | 1.57 | -0.49 | -0.49 | -0.14 | -0.04 | -0.27 | 1.24 | 1.64 | 1.32 | 0.92 |
PAT Before Extraordinary Items | - | 13.87 | 8.64 | 15.1 | 19.36 | 12.68 | 8.75 | 8.91 | 5.13 | 3.3 | 2.67 | 1.81 |
Net Profit | 10.75 | 13.87 | 8.64 | 15.1 | 19.36 | 12.68 | 8.75 | 8.91 | 5.13 | 3.3 | 2.67 | 1.81 |
Net Profit Margin (%) | - | 9.29 | 9.21 | 16.14 | 19.49 | 14.93 | 14.4 | 18.59 | 11.76 | 8.06 | 6.26 | 4.37 |
EPS (Adjusted) | - | 8.8 | 5.48 | 9.59 | 12.29 | 8.05 | 5.56 | 5.66 | 3.26 | 2.1 | 1.69 | 1.15 |
Valuation & Key Ratios
Performance Metrics
| Metric | TTM | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | Mar '16 | Mar '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Book Value Per Share | - | 252.47 | 240.42 | 200.7 | 188.57 | 130.63 | 121.67 | 115.92 | 107.55 | 50.32 | 40.67 | 32.87 |
Return on Assets (ROA) % | - | 2.71 | 1.83 | 4.14 | 6.09 | 5.69 | 4.69 | 4.99 | 8.58 | 8.59 | 7.22 | 7.89 |
Return on Equity (ROE) % | - | 3.48 | 2.3 | 5.19 | 7.08 | 7.04 | 5.22 | 5.58 | 11.34 | 19.17 | 19.18 | 16.07 |
Return on Capital Employed (ROCE) % | - | 4.78 | 3.38 | 5.28 | 7.2 | 7.04 | 5.72 | 5.9 | 14.73 | 25.9 | 22.88 | 25.81 |
Profitability Ratios | - | - | - | - | - | - | - | - | - | - | - | - |
Liquidity Ratios | - | - | - | - | - | - | - | - | - | - | - | - |
Valuation Ratios | - | - | - | - | - | - | - | - | - | - | - | - |
Debt to Equity Ratio | - | 0.15 | 0.12 | 0.12 | 0.05 | 0.06 | 0 | 0.05 | 0.14 | 0.53 | 0.62 | 0.04 |
Featured Insight
No recent news available
Key People
M
Mr. Vinod Kumar
Chief Financial Officer
P
Parul Choudhary
Company Secretary,Compliance Officer